SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-058143
Filing Date
2020-05-07
Accepted
2020-05-07 16:37:49
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2015325d1_10q.htm 10-Q 344295
2 EXHIBIT 31.1 tm2015325d1_ex31-1.htm EX-31.1 10096
3 EXHIBIT 31.2 tm2015325d1_ex31-2.htm EX-31.2 9809
4 EXHIBIT 32.1 tm2015325d1_ex32-1.htm EX-32.1 4770
5 EXHIBIT 32.2 tm2015325d1_ex32-2.htm EX-32.2 4805
  Complete submission text file 0001104659-20-058143.txt   2541838

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ancn-20200331.xml EX-101.INS 522192
7 XBRL TAXONOMY EXTENSION SCHEMA ancn-20200331.xsd EX-101.SCH 29703
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ancn-20200331_cal.xml EX-101.CAL 26955
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ancn-20200331_def.xml EX-101.DEF 81661
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ancn-20200331_lab.xml EX-101.LAB 249068
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ancn-20200331_pre.xml EX-101.PRE 183047
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38807 | Film No.: 20857078
SIC: 2834 Pharmaceutical Preparations